Amphastar Pharmaceuticals (AMPH) Intangibles (2013 - 2026)

Amphastar Pharmaceuticals' Intangibles history runs 14 years deep, the most recent figure standing at $29.2 million for Q1 2026.

• In Q1 2026, Intangibles changed 0.0% year-over-year to $29.2 million; the TTM figure through Mar 2026 stood at $29.2 million (changed 0.0% YoY), while the FY2025 annual figure was $29.2 million, changed 0.0% from the prior year.
• Intangibles was $29.2 million for Q1 2026 at Amphastar Pharmaceuticals, roughly flat from $29.2 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $29.2 million in Q2 2022 to a low of $29.2 million in Q1 2022.
• Historically, Intangibles has averaged $29.2 million across 5 years, with a median of $29.2 million in 2022.
• Biggest YoY gain for Intangibles was 0.09% in 2022; the steepest drop was 0.09% in 2022.
• A 5-year view of Intangibles shows it stood at $29.2 million in 2022, then changed by 0.0% to $29.2 million in 2023, then changed by 0.0% to $29.2 million in 2024, then changed by 0.0% to $29.2 million in 2025, then changed by 0.0% to $29.2 million in 2026.
• The last three Intangibles figures came in at $29.2 million (Q1 2026), $29.2 million (Q4 2025), and $29.2 million (Q3 2025), per Business Quant data.